Jeffrey Cleland

Director at Elixirgen Therapeutics

Capital raised by Elixirgen Therapeutics

$8.2M+$4.0M latest round

3 Form D filings · first filed Jan 2025 · Baltimore, MD

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 3
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 2 ↗

Career

1 company on file

Elixirgen TherapeuticsBiotech · Baltimore, MDsince Jan 2025

Director

Listed on Elixirgen Therapeutics's Form D filings

Company filings

via EDGAR · Form D for Elixirgen Therapeutics3

DateCompanyFormAmountRole on filing

Oct 30, 2025Elixirgen TherapeuticsForm D+$4.0M—

Form DOct 30, 2025 · Elixirgen Therapeutics+$4.0Mnot a signer

Mar 31, 2025Elixirgen TherapeuticsForm D+$3.6M—

Form DMar 31, 2025 · Elixirgen Therapeutics+$3.6Mnot a signer

Jan 30, 2025Elixirgen TherapeuticsForm D+$600K—

Form DJan 30, 2025 · Elixirgen Therapeutics+$600Knot a signer

Overview

Last filing Oct 30, 2025

Jeffrey Cleland is on file as Director at Elixirgen Therapeutics in Baltimore, MD. Elixirgen Therapeutics has 3 Form D filings on record, $8.2M raised in total.

Teammates

Elixirgen Therapeutics · 1

Akihiro KoChief Executive OfficerSigner

Products

Elixirgen Therapeutics · 1

mRNA Therapeutic PlatformRNA Therapeutics

Elixirgen Therapeutics' mRNA platform is at the forefront of developing innovative therapeutics designed to address rare and complex diseases. This platform enables the creation of potent treatments that can potentially modulate genetic expressions to treat conditions effectively.